PDS Biotechnology (PDSB) Insider Trading & Ownership $2.09 -0.11 (-5.00%) (As of 11/22/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PDS Biotechnology (NASDAQ:PDSB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.50%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$26,071.00Number OfInsiders Selling(Last 3 Years)0 Get PDSB Insider Trade Alerts Want to know when executives and insiders are buying or selling PDS Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PDSB Insider Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. PDS Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2021Matthew C HillCFOBuy2,900$8.99$26,071.00 (Data available from 1/1/2013 forward) PDSB Insider Trading Activity - Frequently Asked Questions Who is on PDS Biotechnology's Insider Roster? The list of insiders at PDS Biotechnology includes Matthew C Hill. Learn more on insiders at PDSB. What percentage of PDS Biotechnology stock is owned by insiders? 9.50% of PDS Biotechnology stock is owned by insiders. Learn more on PDSB's insider holdings. PDS Biotechnology Key ExecutivesDr. Frank K. Bedu-Addo Ph.D. (Age 59)President, CEO & Director Compensation: $853.85kDr. Gregory L. Conn Ph.D. (Age 69)Chief Scientific Officer Compensation: $194.67kMr. Lars Robert Boesgaard M.B.A. (Age 54)Principal Financial & Accounting Officer and CFO Mr. Stephan Toutain M.B.A. (Age 58)M.S., Chief Operating Officer Dr. Joe J. DervanVP of Research & DevelopmentMs. Deanne RandolphHead of Investor RelationsMr. Spencer Brown J.D. (Age 54)Senior VP, General Counsel, Corporate Secretary & Compliance Officer Dr. Kirk V. Shepard M.D. (Age 72)Chief Medical Officer Ms. Janetta Trochimiuk (Age 61)Controller More Insider Trading Tools from MarketBeat Related Companies Inovio Pharmaceuticals Insider Ownership Jasper Therapeutics Insider Ownership Cryoport Insider Ownership Design Therapeutics Insider Ownership Kodiak Sciences Insider Ownership Aclaris Therapeutics Insider Ownership COMPASS Pathways Insider Ownership iTeos Therapeutics Insider Ownership Sage Therapeutics Insider Ownership Voyager Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:PDSB) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
